Tuesday, April 25, 2017

Immunology and Cell Biology - Table of Contents alert Volume 95 Issue 4

If you are unable to see the message below, click here to view.
Immunology and Cell Biology

Nature Milestones: Interactive antibody timeline

Nature Milestones: Antibodies presents an interactive timeline on the history of antibodies covering everything from their initial description in antisera through to their application in immunotherapy. The timeline includes written content, video interviews and animations. 

Access the timeline free online

Produced with support from

The April 2017 issue of Immunology & Cell Biology contains a Special Feature on Cancer Immunotherapy. This series of reviews highlights some of the recent advances in mobilizing effective host immunity to cancer. Cancer immunotherapy is at a critical and exciting stage of development. Progress in our understanding of cancer immunotherapy has been dramatic over recent years and we have selected six articles to highlight in this Special Feature. The Special Feature begins with an overview of the approaches to targeting inflammation in the cancer microenvironment and follows with a focus of extracellular adenosine as a major immunosuppressive metabolite in tumours. Two subsequent articles detail advances in antibody engineering for engaging the ideal effector responses in tumours and the Special Feature finishes with two articles that explore new approaches in adoptive cellular therapy targeted at tumor and virus specific antigens in tumors. Immunology & C ell Biology thanks the coordinator of this Special Feature – Mark Smyth – for his planning and input.

Please see articles marked


Volume 95, Issue 4 (April 2017)

In this issue
News and Commentary
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

News and Commentary


When input does not match output, lung-resident memory T cells decay

Linda M Wakim

Immunol Cell Biol 2017 95: 321-322; advance online publication, March 14, 2017; 10.1038/icb.2017.14

Full Text



Multiple approaches to immunotherapy - the new pillar of cancer treatment  

Mark J Smyth

Immunol Cell Biol 2017 95: 323-324; 10.1038/icb.2017.9

Full Text | PDF



Targeting cancer-related inflammation in the era of immunotherapy  

Kyohei Nakamura and Mark J Smyth

Immunol Cell Biol 2017 95: 325-332; advance online publication, January 10, 2017; 10.1038/icb.2016.126

Abstract | Full Text

Targeting A2 adenosine receptors in cancer  

David Allard, Martin Turcotte and John Stagg

Immunol Cell Biol 2017 95: 333-339; advance online publication, February 8, 2017; 10.1038/icb.2017.8

Abstract | Full Text

Role of Fc–FcγR interactions in the antitumor activity of therapeutic antibodies  

Bryan C Barnhart and Michael Quigley

Immunol Cell Biol 2017 95: 340-346; advance online publication, December 15, 2016; 10.1038/icb.2016.121

Abstract | Full Text

Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells  

Maria Carmen Ochoa, Luna Minute, Inmaculada Rodriguez, Saray Garasa, Elisabeth Perez-Ruiz, Susana Inogés, Ignacio Melero and Pedro Berraondo

Immunol Cell Biol 2017 95: 347-355; advance online publication, February 21, 2017; 10.1038/icb.2017.6

Abstract | Full Text

CAR T-cell therapy of solid tumors  

Carmen S M Yong, Valerie Dardalhon, Christel Devaud, Naomi Taylor, Phillip K Darcy and Michael H Kershaw

Immunol Cell Biol 2017 95: 356-363; advance online publication, December 22, 2016; 10.1038/icb.2016.128

Abstract | Full Text

Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine  

Corey Smith and Rajiv Khanna

Immunol Cell Biol 2017 95: 364-371; advance online publication, January 10, 2017; 10.1038/icb.2016.127

Abstract | Full Text

Original Articles


Monocytic thrombomodulin promotes cell adhesion through interacting with its ligand, Lewisy OPEN

Wei-Ling Lin, Chia-Chi Chen, Guey-Yueh Shi, Chih-Yuan Ma, Chuan-Fa Chang and Hua-Lin Wu

Immunol Cell Biol 2017 95: 372-379; advance online publication, November 3, 2016; 10.1038/icb.2016.110

Abstract | Full Text

Hypoxic modulation of hepatocyte responses to the cytokine interleukin-22

Scott A Budda, Krishna Bhattarai, Justine L Alexander and Lauren A Zenewicz

Immunol Cell Biol 2017 95: 380-387; advance online publication, October 31, 2016; 10.1038/icb.2016.107

Abstract | Full Text

Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway

Lis N Velásquez, M Ayelén Milillo, M Victoria Delpino, Aldana Trotta, M Florencia Mercogliano, Roberto G Pozner, Roxana Schillaci, Patricia V Elizalde, Guillermo H Giambartolomei and Paula Barrionuevo

Immunol Cell Biol 2017 95: 388-398; advance online publication, November 29, 2016; 10.1038/icb.2016.111

Abstract | Full Text

Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis

Jie Luo, Yuejin Liang, Fanping Kong, Jingfan Qiu, Xinjian Liu, Ailing Chen, Bruce A Luxon, Hannah W Wu and Yong Wang

Immunol Cell Biol 2017 95: 399-407; advance online publication, November 3, 2016; 10.1038/icb.2016.109

Abstract | Full Text

Short Communication


Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation

Christian Büll, Estel Collado-Camps, Esther D Kers-Rebel, Torben Heise, Jonas N Søndergaard, Martijn H den Brok, Barbara M Schulte, Thomas J Boltje and Gosse J Adema

Immunol Cell Biol 2017 95: 408-415; advance online publication, November 22, 2016; 10.1038/icb.2016.105

Abstract | Full Text



Decidual vascular endothelial cells promote maternal–fetal immune tolerance by inducing regulatory T cells through canonical Notch1 signaling

Yanyi Yao, Jieping Song, Weipeng Wang and Nian Liu

Immunol Cell Biol 2017 95: 416; 10.1038/icb.2017.12

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Immunology & Cell Biology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: